Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLD-1433 kills various viruses within seconds

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jul 12, 2022 11:02am

166 Views

Post# 34817981

RE:RE:RE:RE:RE:TLD-1433 kills various viruses within seconds

It immediatley solves any perceived Money $$ problem doesn't it? Also gives them an immediate revenue stream that is probably larger, in the short term, than NMIBC... Like having a major Cancer indication under their belt... Instantly. :-)

StevenBirch wrote: And we sort of know the timeline for NMIBC data to come in, not too far away, but this could come at any time. I'm back to eagerly looking for a news release every morning if not the daily trading that follows.

Rumpl3StiltSkin wrote: Yes, this would be huge for TLT. Should see a corresponding spike in SP of a cpl $$s at least.

ScienceFirst wrote:
Lesalpes29 ... What's interesting with the COVID-19 indication is that if the last preclinical milestone (the current animal testing) is successful, then NML will recommand us for government funding (securing doses by the government, etc ...), just like it happened for other COVID-19 innovations (MEDICAGO, etc ...).

And a recommandation from NML would instantly bring a credibility that could no more be ignored anymore by big pharmas as NML has a worldwide credibility (Ebola, etc ...).

Regarding the duration of a possible COVID-19 trials, let's just say that MEDICAGO did it from A to Z in 1.5 years, given that the pool of COVID-19 is much larger than one of an oncology indication.

______________

Lesalpes29 - (7/12/2022 8:01:44 AM)

RE:TLD-1433 kills various viruses within seconds

April 9th of last year we had the first TLT NR about a possible vaccine develop by TLT and their tech. 15 months later we are still waiting to see if it's working on animals? If positive results it could take an other 1 year +? BTD well before hopefully!